Blocking the active site of thiolase

A key feature of the active site of the trypanosomal thiolase is the HDCF-loop (HIS-ASP-CYS-PHE), visualised in light blue.

A key feature of the active site of the trypanosomal thiolase is the HDCF-loop (HIS-ASP-CYS-PHE), visualised in light blue. © University of Oulu

Scientists at the University of Oulu, Finland, and at the HZB break new ground for drug discovery research in the fight against sleeping sickness

Scientists at the University of Oulu, Finland, and at the Helmholtz Center Berlin (HZB) have shown the way to new directions in drug development against African sleeping sickness and other tropical parasitic infections. This was based on the structural analysis of the enzyme thiolase, which plays a central role in lipid metabolism in the parasite that causes sleeping sickness. The researchers examined the biomolecule’s structure at the MX beamline of electron storage ring, BESSY II, at the HZB. (Biochemical J. 2013, DOI: 10.1042/BJ20130669)

Sleeping sicknesses – african trypanosomiasis, kala-azar, indian leishmaniasis – are infections caused by tropical parasites. Millions get sick from them each year and thousands end up dying. Anti-parasitic drugs are expensive and often have a host of unwanted side effects. In decades, there have been no new effective therapies. Reason enough for the World Health Organization (WHO) to consider research, which can lead to the development of new anti-parasitic drugs, a top priority.

Now, Prof. Rik Wierenga and his team at Oulu University have paved the way for this type of research by shedding light on the structure of the enzyme thiolase. Thiolase figures prominently in parasitic lipid metabolism. According to Wierenga, “key is knowing the geometry of the enzyme’s active site. This is the place where lipids that play a central role in parasitic metabolism attach and where chemical reactions that convert lipids into other substances take place.” Which is why it’s important to investigate the active site’s structure and function: “It enables us to develop lipid-like substances that firmly attach to the active site and block it.” The molecules that are involved represent the ideal starting points for new drug development.
Studies at BESSY of the enzyme thiolase have yielded a highly detailed image of thiolase’s active site. “We now have a much clearer idea of thiolase’s role in all this,” says Wierenga. “It would appear that the enzyme catalyzes the first step in the sterol biosynthesis pathway, which is important in a number of parasites.”

“The measurements of crystalline thiolase proteins we obtained at our MX beamline has helped to unravel the active site’s geometry,” says HZB’s own Dr. Manfred Weiss. One particular region of the protein called the HDCF loop turns out to be key. The structure, which lies deep within thiolase’s interior, was previously unknown. “Understanding the HDCF loop is the ideal starting point for the development of new anti-parasitic drugs,” adds Wierenga.

Original publication:
Harijan, R.K., Kiema, T.R., Karjalainen, M.P., Janardan, N., Murthy, M.R., Weiss. M.S., Michels, P.A., Wierenga, R.K. (2013) Crystal structures of SCP2-thiolases of Trypanosomatidae, human pathogens causing widespread tropical diseases: the importance for catalysis of the cysteine of the unique HDCF loop. Biochem J., 455, 119-130.

HS

  • Copy link

You might also be interested in

  • Lithium-sulphur pouch cells investigated at BESSY II
    Science Highlight
    08.01.2025
    Lithium-sulphur pouch cells investigated at BESSY II
    A team from HZB and the Fraunhofer Institute for Material and Beam Technology (IWS) in Dresden has gained new insights into lithium-sulphur pouch cells at the BAMline of BESSY II. Supplemented by analyses in the HZB imaging laboratory and further measurements, a new picture emerges of processes that limit the performance and lifespan of this industrially relevant battery type. The study has been published in the prestigious journal Advanced Energy Materials.
  • Largest magnetic anisotropy of a molecule measured at BESSY II
    Science Highlight
    21.12.2024
    Largest magnetic anisotropy of a molecule measured at BESSY II
    At the Berlin synchrotron radiation source BESSY II, the largest magnetic anisotropy of a single molecule ever measured experimentally has been determined. The larger this anisotropy is, the better a molecule is suited as a molecular nanomagnet. Such nanomagnets have a wide range of potential applications, for example, in energy-efficient data storage. Researchers from the Max Planck Institute for Kohlenforschung (MPI KOFO), the Joint Lab EPR4Energy of the Max Planck Institute for Chemical Energy Conversion (MPI CEC) and the Helmholtz-Zentrum Berlin were involved in the study.
  • Ernst Eckhard Koch Prize and Synchrotron Radiation Innovation Award
    News
    13.12.2024
    Ernst Eckhard Koch Prize and Synchrotron Radiation Innovation Award
    This year, the Friends of Helmholtz-Zentrum Berlin (Freundeskreis des HZB e. V.) awarded the Ernst Eckhard Koch Prize to Dr. Dieter Skroblin of the Technische Universität Berlin for his outstanding doctoral thesis. The European Innovation Award Synchrotron Radiation went to Dr. Manfred Faubel from the Max Planck Institute for Dynamics and Self-Organization in Göttingen and Dr. Bernd Winter from the Fritz Haber Institute in Berlin. The award ceremony took place at this year's HZB user meeting.